• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / Stocks

These 2 Value Portfolios Are Doing OK, Relatively Speaking

The two portfolios, one active and the other passive, have sagged with the broader market but still are outperforming a pair of Russell value indices.
By JONATHAN HELLER
Apr 01, 2020 | 10:00 AM EDT
Stocks quotes in this article: ASTE, CWGL, DRQ, FIT, JOUT, RAMP, HZO, NPK, OSUR, CYBE, ONTO

I thought I would try and get back to normal (whatever that is) at least for one column and provide an update on one of my current value tracking portfolio experiments.

Five months since inception, my Triple Net active versus passive portfolio experiment rolls on in a very difficult market environment. This is the kind of stress test that no one wants to experience, but it's here whether we like it or not.

The idea here was to determine whether taking a scattergun approach to buying companies at relatively low multiples of net current assets (current assets minus total liabilities) could outperform a more active approach. Of course, inherent in the approach is the belief that either group should outperform the markets over the long-term.

The original screening criteria included the following:

  • Market capitalization in excess of $100 million
  • No financials or development-stage companies
  • Trading at between 2 and 3 times net current asset value, or NCAV, which is calculated by subtracting a company's total liabilities from current assets)

The 48 qualifying names represent the "passive" portfolio; I then honed this list down to the eight that I found most interesting, which comprise the "active" portfolio

So far, since its October inception, my active portfolio, comprised of Astec Industies (ASTE) (up 13%), Crimson Wine Group (CWGL) (down 17%), Dril-Quip (DRQ) (down 40%), Fitbit (FIT) (up 93%), Johnson Outdoors (JOUT) (up 5%), LiveRamp Holdings (RAMP) (down 18%), MarineMax (HZO) (down 35%) and National Presto Industries (NPK) (down 14%), is down about 1%, but still outperforming the passive portfolio (down 17%). During that same time frame, the Russell 2000 Value Index is down 31% while the Russell Microcap Value Index is down 30%. (The Russell 2000 Index, which includes both growth and value components, is off 24%, while the Russell Microcap Index has fallen 23%).

Both the active and passive portfolios have had dramatic drops since the last update in January; at that point the active portfolio was up 25%, which was better than the passive portfolio (up 16%). While absolute performance is still disappointing, relative performance, especially of the active portfolio, is at the very least intriguing.

Of course, the active portfolio's return is driven by the performance of Fitbit, which still is benefitting from its pending acquisition by Alphabet Inc. at $7.35 a share, although as each day passes I wonder whether that deal will ever be completed. FIT currently trades at 9% below the deal price. Excluding FIT's performance, the active portfolio would be down about 15%, still in line with the passive portfolio and ahead of the benchmarks.

The top performers in the "passive" portfolio (which included all members of the "active" portfolio plus 40 other qualifiers), besides FIT, include OraSure Technologies (OSUR) (up 30%), which is benefitting from its Covid-19 collection devices, CyberOptics (CYBE) (up 16%), Astec Industries and Onto Innovation (ONTO) (up 10%).

Just nine of the passive portfolio members are in positive territory at this writing.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Heller had no positions in the stocks mentioned.

TAGS: Indexes | Investing | Stocks | Value Investing | Real Money

More from Stocks

A 'Mag'nificent Way to Play an AdTech Rebound

Bret Jensen
May 15, 2022 9:15 PM EDT

Similar to biotech, the small adtech space has been hammered in recent quarters and has likely hit oversold territory.

Bearish Bets: 3 Sluggish Stocks You Should Consider Shorting This Week

Bob Lang
May 15, 2022 10:30 AM EDT

These recently downgraded names are displaying both quantitative and technical deterioration.

10 Tips for Clawing Ahead in a Bear Market

James "Rev Shark" DePorre
May 14, 2022 10:00 AM EDT

Remember, behind every bear market a bull is waiting. Here's how to survive and thrive while stocks growl.

We Rallied, but Don't Get Too Comfortable

James "Rev Shark" DePorre
May 13, 2022 4:29 PM EDT

The action Friday is a good start, but it requires much more work before it can be trusted.

3 Undervalued High Dividend Stocks Yielding Over 5%

Bob Ciura
May 13, 2022 2:15 PM EDT

Selloffs like what we've experienced in 2022 bring with them more favorable valuations, and higher dividend yields for quality names.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:14 PM EDT PAUL PRICE

    A new, very scary movie

  • 08:51 AM EDT PAUL PRICE

    Advice from the future...

  • 12:20 PM EDT PAUL PRICE

    A blast from the past regarding Bitcoin

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login